1 | 137234-62-9 | 伏立康唑 | Voriconazole | C16H14F3N5O
| 伏立康唑 | |
2 | 137234-63-0 | α-(2,4-二氟苯基)-5-氟-β-甲基-α-(1,2,4-三唑-1-甲基)-4- 嘧啶乙醇 | ent-Voriconazole | C16H14F3N5O
| 中间体;杂质对照品;103-伏立康唑;对照品-杂质对照品 | |
3 | | Voriconazole-13C3 | Voriconazole-13C3 | C16H14F3N5O
| Inhibitors;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals | |
4 | 173967-54-9 | 活力康唑 | Voriconazole Vfend | C16H14F3N5O
| | |
5 | 239807-03-5 | 伏立康唑杂质8 | Voriconazole Impurity 8 | C16H14F3N5O
| 伏立康唑 | |
6 | 239807-03-5 | 伏立康唑杂质11 | Voriconazole Impurity 11 | C16H14F3N5O
| 伏立康唑 | |
7 | 1217661-14-7 | rel-(R,S)-Voriconazole-d3 | rel-(R,S)-Voriconazole-d3 | C16H14F3N5O
| | |
8 | | N-[1-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]-N'-[2-(trifluoromethyl)phenyl]urea | N-[1-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-yl]-N'-[2-(trifluoromethyl)phenyl]urea | C16H14F3N5O
| | |
9 | 336176-35-3 | 2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO]-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-IMIDAZOL-5-OL | 2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO]-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-IMIDAZOL-5-OL | C16H14F3N5O
| | |
10 | | 4-[3-(4-METHOXYPHENYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-6-METHYLPYRIMIDIN-2-AMINE | 4-[3-(4-METHOXYPHENYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-6-METHYLPYRIMIDIN-2-AMINE | C16H14F3N5O
| | |
11 | 957502-03-3 | N-[6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-pyrimidinyl]-N-[4-(trifluoromethoxy)phenyl]amine | N-[6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-pyrimidinyl]-N-[4-(trifluoromethoxy)phenyl]amine | C16H14F3N5O
| | |
12 | 927880-89-5 | N1-甲基-4-[[2-[5-(三氟甲基)-1H-咪唑-2-基]-4-P吡啶基]氧基]-1,2-苯二胺 | 1,2-BENZENEDIAMINE, N1-METHYL-4-[[2-[5-(TRIFLUOROMETHYL)-1H-IMIDAZOL-2-YL]-4-PYRIDINYL]OXY]- | C16H14F3N5O
| | |
13 | | 4-amino-2,6-dimethyl-5-{5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl}-2,3-dihydropyridazin-3-one | 4-amino-2,6-dimethyl-5-{5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-3-yl}-2,3-dihydropyridazin-3-one | C16H14F3N5O
| | |
14 | 188416-29-7 | (2R,3S|2S,3R)-2-(2,4-二 氟 苯 基)-3-(5-氟 嘧 啶 -4-基)-1-(1H-1,2,4-三唑- 1-基)-2-丁醇 | ( 2R,3S|2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-yl)-2-butanol | C16H14F3N5O
| 系列1;伏立康唑中间体 | |
15 | 182230-43-9 | (2R,3S|2S,3R)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑- 1-基)-2-丁醇 | (2r,3s|2s,3r)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol | C16H14F3N5O
| 有机原料;醇类化合物 | |
16 | | (2R,3S)-3-(5-FLUOROPYRIMIDINE-4-YL)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIAZOLE-1-YL)BUTYL-2-ALCOHOL | (2R,3S)-3-(5-FLUOROPYRIMIDINE-4-YL)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIAZOLE-1-YL)BUTYL-2-ALCOHOL | C16H14F3N5O
| | |
17 | | (2R,3S/2S,3R)-3-(5-FLUOROPYRIMIDINE-4-YL)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIAZOLE-1-YL) BUTYL-2-ALCOHOL | (2R,3S/2S,3R)-3-(5-FLUOROPYRIMIDINE-4-YL)-2-(2,4-DIFLUOROPHENYL)-1-(1H-1,2,4-TRIAZOLE-1-YL) BUTYL-2-ALCOHOL | C16H14F3N5O
| (intermediate of voriconazole) | |